Updated REMS for Rosiglitazone-containing Medicines

Published Online: Friday, October 21, 2011
Follow Pharmacy_Times:
Listen as Catherine Chew, a pharmacist in the FDA’s Division of Drug Information, describes the restrictions for prescribing and using rosiglitazone-containing medicines, including type 2 diabetes medications Avandia, Avandamet, and Avandaryl.

Click here to access the podcast.
Related Articles
The FDA refused to approve the ultra-long-acting insulin treatments 2 years ago.
Team-based care and the importance of relationships between pharmacists and physicians were the emphasis of the keynote address at the American Pharmacists Association 2015 annual meeting.
The University of Mississippi School of Pharmacy will be installing 3 new nuclear magnetic resonance (NMR) spectrometers that aid in drug discovery.
A pharmacist in Cleveland, Tennessee, has surrendered her license following an investigation into her compounding pharmacy’s use of potentially unsafe ingredients.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$